Skip to main content
SpringerLink
Log in

Health-Related Quality of Life and Patient-Reported Outcomes

  • Chapter
  • First Online:
Intraperitoneal Therapy for Ovarian Cancer

  • 471 Accesses

Abstract

The World Health Organization (WHO) in its constitution defines health as “a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity” [1]. Increasingly, health is no longer being measured exclusively by the clinical features of disease. Family, caregiver, and patient-reported health outcomes are gaining importance from the earliest phases of clinical research to the implementation of public health policies. Health outcomes are no longer limited to survival or mortality, but now include many aspects of well-being, such as morbidity, comfort, satisfaction, psychosocial function, social support, health status, clinical factors, and economic factors [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. WHO. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19–22 June 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no 2, p 100) and entered into force on 7 April 1948

    Google Scholar 

  2. Lipscomb J, Donaldson MS, Arora NK, Brown ML, Clauser SB, Potosky AL et al (2004) Cancer outcomes research. J Natl Cancer Inst monographs (33):178–197

    Google Scholar 

  3. Goodman MT, Correa CN, Tung KH, Roffers SD, Cheng Wu X, Young JL Jr et al (2003) Stage at diagnosis of ovarian cancer in the United States, 1992–1997. Cancer 97(10 suppl):2648–2659

    Article  PubMed  Google Scholar 

  4. Krouse R, Aziz NM (2008) Cancer survivorship. In: Alberts DS, Hess LM (eds) Fundamentals of cancer prevention. Springer, Heidelberg

    Google Scholar 

  5. Ferrell B, Smith SL, Cullinane CA, Melancon C (2003) Psychological well being and quality of life in ovarian cancer survivors. Cancer 98(5):1061–1071

    Article  PubMed  Google Scholar 

  6. Ferrell BR, Smith SL, Ervin KS, Itano J, Melancon C (2003) A qualitative analysis of social concerns of women with ovarian cancer. Psycho-oncology 12(7):647–663

    Article  PubMed  Google Scholar 

  7. Houck K, Avis NE, Gallant JM, Fuller AF Jr, Goodman A (1999) Quality of life in advanced ovarian cancer: identifying specific concerns. J Palliat Med 2(4):397–402

    Article  PubMed  CAS  Google Scholar 

  8. Montazeri A, McEwen J, Gillis CR (1996) Quality of life in patients with ovarian cancer: current state of research. Support Care Cancer 4(3):169–179

    Article  PubMed  CAS  Google Scholar 

  9. Sun CC, Bodurka DC, Weaver CB, Rasu R, Wolf JK, Bevers MW et al (2005) Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer 13(4):219–227

    Article  PubMed  Google Scholar 

  10. IOM (2008) Cancer care for the whole patient. National Academy Press, Washington, DC

    Google Scholar 

  11. Passik SD, Kirsh KL (2005) A pilot examination of the impact of cancer patients’ fatigue on their spousal caregivers. Palliat Support Care 3(4):273–279

    Article  PubMed  Google Scholar 

  12. Awadalla AW, Ohaeri JU, Gholoum A, Khalid AO, Hamad HM, Jacob A (2007) Factors associated with quality of life of outpatients with breast cancer and gynecologic cancers and their family caregivers: a controlled study. BMC Cancer 7:102

    Article  PubMed  Google Scholar 

  13. Le T, Leis A, Pahwa P, Wright K, Ali K, Reeder B (2003) Quality-of-life issues in patients with ovarian cancer and their caregivers: a review. Obstet Gynecol Surv 58(11):749–758

    Article  PubMed  CAS  Google Scholar 

  14. Ponto JA, Barton D (2008) Husbands’ perspective of living with wives’ ovarian cancer. Psycho-oncology 17(12):1225–1231

    Article  PubMed  Google Scholar 

  15. Donabedian A (1980) The definition of quality: a conceptual exploration. Explorations in quality assessment and monitoring. Health Administration Press, Ann Arbor

    Google Scholar 

  16. Berzon RA, Lobo FS (2006) Measuring health-related quality of life within clinical research studies. In: Chumney ECG, Simpson KN (eds) Methods and designs for outcomes research. American Society of Health-System Pharmacists, Bethesda, MD

    Google Scholar 

  17. Bond J, Corner L (2004) Explaining quality of life. In: Corner L (ed) Quality of life and older people. Open University Press, Maidenhead

    Google Scholar 

  18. FDA (2006) Patient-reported outcome measures: use in medical product development to support labeling claims [cited June 15, 2009]. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071975.pdf

  19. Fries JF, Krishnan E, Bruce B (2009) Items, instruments, crosswalks, and PROMIS. J Rheumatol 36(6):1093–1095

    Article  PubMed  Google Scholar 

  20. Salek S (1999) Compendium of quality of life instruments. Chichester, Wiley

    Google Scholar 

  21. Coons SJ, Craig BM (2008) Assessing human and economic benefits of cancer prevention. In: Alberts DS, Hess LM (eds) Fundamentals of cancer prevention. Springer, Heidelberg

    Google Scholar 

  22. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R (2002) Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 324(7351):1417

    Article  PubMed  Google Scholar 

  23. Gil KM, Gibbons HE, Jenison EL, Hopkins MP, von Gruenigen VE (2007) Baseline characteristics influencing quality of life in women undergoing gynecologic oncology surgery. Health Qual Life Outcomes 5:25

    Article  PubMed  Google Scholar 

  24. von Gruenigen VE, Frasure HE, Jenison EL, Hopkins MP, Gil KM (2006) Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy. Gynecol Oncol 103(1):120–126

    Article  Google Scholar 

  25. Ware JE (2009) SF-35 health survey update [cited June 29, 2009]. http://www.sf-36.org/tools/sf36.shtml

  26. Ware JE, Kosinski M, Keller SD (1996) A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34(3):220–233

    Article  PubMed  Google Scholar 

  27. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579

    PubMed  CAS  Google Scholar 

  28. Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA, Webster K, Cella D, Hu S et al (2001) Reliability and validity of the functional assessment of cancer therapy-ovarian. J Clin Oncol 19(6): 1809–1817

    PubMed  CAS  Google Scholar 

  29. Greimel E, Bottomley A, Cull A, Waldenstrom AC, Arraras J, Chauvenet L et al (2003) An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer 39(10):1402–1408

    Article  PubMed  CAS  Google Scholar 

  30. Bonomi AE, Shikiar R, Legro MW (2000) Quality-of-life assessment in acute, chronic, and cancer pain: a pharmacist’s guide. J Am Pharm Assoc 40(3):402–416

    CAS  Google Scholar 

  31. Kemmler G, Holzner B, Kopp M, Dunser M, Margreiter R, Greil R et al (1999) Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. J Clin Oncol 17(9):2932–2940

    PubMed  CAS  Google Scholar 

  32. King MT (1996) The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 5(6):555–567

    Article  PubMed  CAS  Google Scholar 

  33. Cull A, Howat S, Greimel E, Waldenstrom AC, Arraras J, Kudelka A et al (2001) Development of a European organization for research and treatment of cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report. Eur J Cancer 37(1):47–53

    Article  PubMed  CAS  Google Scholar 

  34. Schipper H, Clinch J, McMurray A, Levitt M (1984) Measuring the quality of life of cancer patients: the functional living index-cancer: development and validation. J Clin Oncol 2(5):472–483

    PubMed  CAS  Google Scholar 

  35. Finkelstein DM, Cassileth BR, Bonomi PD, Ruckdeschel JC, Ezdinli EZ, Wolter JM (1988) A pilot study of the functional living index-cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol 11(6):630–633

    Article  PubMed  CAS  Google Scholar 

  36. King M (1999) Responsiveness of the functional living index-cancer (FLIC) and the EORTC core quality of life (QOL) module (QLQ-C30). Qual Life Res 8(7):610

    Google Scholar 

  37. Wilson RW, Hutson LM, Vanstry D (2005) Comparison of 2 quality-of-life questionnaires in women treated for breast cancer: the RAND 36-item health survey and the functional living index-cancer. Phys Ther 85(9):851–860

    PubMed  Google Scholar 

  38. Turner RR, Quittner AL, Parasuraman BM, Kallich JD, Cleeland CS, Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group (2007) Patient-reported outcomes: instrument development and selection issues. Value Health 10(suppl 2):S86–S93

    Article  PubMed  Google Scholar 

  39. Mauskopf J (2006) Utility assessment. In: Chumney ECG, Simpson KN (eds) Methods and designs for outcomes research. American Society of Health-System Pharmacists, Inc., Bethesda, MD

    Google Scholar 

  40. Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21(2):271–292

    Article  PubMed  Google Scholar 

  41. Horsman J, Furlong W, Feeny D, Torrance G (2003) The health utilities index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes 1:54

    Article  PubMed  Google Scholar 

  42. Pickard AS, Wilke CT, Lin HW, Lloyd A (2007) Health utilities using the EQ-5D in studies of cancer. Pharmacoeconomics 25(5):365–384

    Article  PubMed  Google Scholar 

  43. Gelber RD, Goldhirsch A, Cole BF, International Breast Cancer Study Group (1993) Evaluation of effectiveness: Q-TWiST. Cancer Treat Rev 19(suppl A):73–84

    Article  PubMed  Google Scholar 

  44. Limat S, Woronoff-Lemsi MC, Menat C, Madroszyk-Flandin A, Merrouche Y (2004) From randomised clinical trials to clinical practice: a pragmatic cost-effectiveness analysis of paclitaxel in first-line therapy for advanced ovarian cancer. Pharmacoeconomics 22(10):633–641

    Article  PubMed  CAS  Google Scholar 

  45. Garcia SF, Cella D, Clauser SB, Flynn KE, Lad T, Lai JS et al (2007) Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol 25(32):5106–5112

    Article  PubMed  Google Scholar 

  46. Rose M, Bjorner JB, Becker J, Fries JF, Ware JE (2008) Evaluation of a preliminary physical function item bank supported the expected advantages of the patient-reported outcomes measurement information system (PROMIS). J Clin Epidemiol 61(1):17–33

    Article  PubMed  CAS  Google Scholar 

  47. Alberts DS, Liu PY, Hannigan EV, O’Toole R, Williams SD, Young JA et al (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 335(26):1950–1955

    Article  PubMed  CAS  Google Scholar 

  48. Davis AL (1991) Adverse effects and quality of life estimates in women receiving intravenous vs intraperitoneal chemotherapy for stage III ovarian cancer. University of Washington, Takoma, Dissertation.

    Google Scholar 

  49. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R et al (1981) Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis 34(12): 585–597

    Article  PubMed  CAS  Google Scholar 

  50. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649–655

    Article  PubMed  CAS  Google Scholar 

  51. Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S et al (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354(1):34–43

    Article  PubMed  CAS  Google Scholar 

  52. Wenzel LB, Huang HQ, Armstrong DK, Walker JL, Cella D (2007) Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 25(4):437–443

    Article  PubMed  CAS  Google Scholar 

  53. Naumann RW, Sukumvanich P, Edwards RP (2009) Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer. Gynecol Oncol 114(1):37–41

    Article  PubMed  Google Scholar 

  54. Hess LM, Alberts DS (2007) The role of intraperitoneal therapy in advanced ovarian cancer. Oncology 21(2):227–232; discussion 32, 35, 39–42

    Google Scholar 

  55. Hess LM, Chambers SK, Hallum A, Janicek M, Buscema J, Slayton L, Chongpison Y, Calley C, Alberts DS (2010) Pilot study of the identification of changes in cognitive function in ovarian cancer patients. submitted

    Google Scholar 

  56. ACOG Committee Opinion No. 396 (2008) Intraperitoneal chemotherapy for ovarian cancer. Obstet Gynecol 111(1):249

    Google Scholar 

  57. Trimble EL, Christian MC (2008) National Cancer Institute-United States strategy regarding intraperitoneal chemotherapy for ovarian cancer. Int J Gynecol Cancer 18(suppl 1):26–28

    Article  PubMed  Google Scholar 

  58. Majdak E, Krasinska L, Mielcarek P, Kobierski J, Kozaka J, Milczek T et al (2002) Comparison of quality of life in patients with advanced ovarian cancer treated with intraperitoneal or intravenous cisplatin and cyclophosphamide as a second line of therapy. Ginekol Pol 73(11): 1096–1102

    PubMed  Google Scholar 

  59. Hess LM, Benham-Hutchins M, Herzog TJ, Hsu CH, Malone DC, Skrepnek GH et al (2007) A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer. Int J Gynecol Cancer 17(3):561–570

    Article  PubMed  CAS  Google Scholar 

  60. Alberts DS, Markman M, Muggia F, Ozols RF, Eldermire E, Bookman MA et al (2006) Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer. Gynecol Oncol 103(3):783–792

    Article  PubMed  CAS  Google Scholar 

  61. Armstrong DK, Brady MF (2006) Intraperitoneal therapy for ovarian cancer: a treatment ready for prime time. J Clin Oncol 24(28):4531–4533

    Article  PubMed  Google Scholar 

  62. Vergote I, Amant F, Leunen K, Cadron I, Van Gorp T, Neven P et al (2008) Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con view. Oncologist 13(4): 410–414

    Article  PubMed  CAS  Google Scholar 

  63. Beck AT, Steer RA (1984) Internal consistencies of the original and revised beck depression inventory. J Clin Psychol 40(6):1365–1367

    Article  PubMed  CAS  Google Scholar 

  64. Norton TR, Manne SL, Rubin S, Carlson J, Hernandez E, Edelson MI et al (2004) Prevalence and predictors of psychological distress among women with ovarian cancer. J Clin Oncol 22(5): 919–926

    Article  PubMed  Google Scholar 

  65. Beck AT, Weissman A, Lester D, Trexler L (1974) The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 42(6):861–865

    Article  PubMed  CAS  Google Scholar 

  66. Mirabeau-Beale KL, Kornblith AB, Penson RT, Lee H, Goodman A, Campos SM et al (2009) Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecol Oncol 114(2):353–359

    Article  PubMed  Google Scholar 

  67. Hann D, Winter K, Jacobsen P (1999) Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 46(5):437–443

    Article  PubMed  CAS  Google Scholar 

  68. van Wilgen CP, Dijkstra PU, Stewart RE, Ranchor AV, Roodenburg JL (2006) Measuring somatic symptoms with the CES-D to assess depression in cancer patients after treatment: comparison among patients with oral/oropharyngeal, gynecological, colorectal, and breast cancer. Psychosomatics 47(6):465–470

    Article  PubMed  Google Scholar 

  69. Szende A, Oppe M, Devlin N (2007) EQ-5D value sets. Springer, Dordrecht

    Book  Google Scholar 

  70. Carter J, Rowland K, Chi D, Brown C, Abu-Rustum N, Castiel M et al (2005) Gynecologic cancer treatment and the impact of cancer-related infertility. Gynecol Oncol 97(1):90–95

    Article  PubMed  Google Scholar 

  71. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R et al (2000) The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26(2):191–208

    Article  PubMed  CAS  Google Scholar 

  72. Whitton AC, Rhydderch H, Furlong W, Feeny D, Barr RD (1997) Self-reported comprehensive health status of adult brain tumor patients using the health utilities index. Cancer 80(2): 258–265

    Article  PubMed  CAS  Google Scholar 

  73. Price MA, Zachariae R, Butow PN, Defazio A, Chauhan D, Espie CA et al (2009) Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor. Eur J Cancer 45(18):3262–70.

    Google Scholar 

  74. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370

    Article  PubMed  CAS  Google Scholar 

  75. McCorkle R, Quint-Benoliel J (1983) Symptom distress, current concerns and mood disturbance after diagnosis of life-threatening disease. Soc Sci Med 17(7):431–438

    Article  PubMed  CAS  Google Scholar 

  76. McCorkle R, Dowd M, Ercolano E, Schulman-Green D, Williams AL, Siefert ML et al (2009) Effects of a nursing intervention on quality of life outcomes in post-surgical women with gynecological cancers. Psychooncology 18(1):62–70

    Article  PubMed  Google Scholar 

  77. Cohen SR, Mount BM (2000) Living with cancer: “good” days and “bad” days – what produces them? Can the McGill quality of life questionnaire distinguish between them? Cancer 89(8): 1854–1865

    Article  PubMed  CAS  Google Scholar 

  78. Cohen SR, Mount BM, Strobel MG, Bui F (1995) The McGill quality of life questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med 9(3):207–219

    Article  PubMed  CAS  Google Scholar 

  79. Cooley ME, McCorkle R, Knafl GJ, Rimar J, Barbieri MJ, Davies M et al (2005) Comparison of health-related quality of life questionnaires in ambulatory oncology. Qual Life Res 14(5): 1239–1249

    Article  PubMed  Google Scholar 

  80. Norton TR, Manne SL, Rubin S, Hernandez E, Carlson J, Bergman C et al (2005) Ovarian cancer patients’ psychological distress: the role of physical impairment, perceived unsupportive family and friend behaviors, perceived control, and self-esteem. Health Psychol 24(2):143–152

    Article  PubMed  Google Scholar 

  81. Ware JE Jr, Manning WG Jr, Duan N, Wells KB, Newhouse JP (1984) Health status and the use of outpatient mental health services. Am Psychol 39(10):1090–1100

    Article  PubMed  Google Scholar 

  82. Mishel MH (1981) The measurement of uncertainty in illness. Nurs Res 30(5):258–263

    Article  PubMed  CAS  Google Scholar 

  83. Schulman-Green D, Ercolano E, Dowd M, Schwartz P, McCorkle R (2008) Quality of life among women after surgery for ovarian cancer. Palliat Support Care 6(3):239–247

    Article  PubMed  Google Scholar 

  84. Holzner B, Kemmler G, Meraner V, Maislinger A, Kopp M, Bodner T et al (2003) Fatigue in ovarian carcinoma patients: a neglected issue? Cancer 97(6):1564–1572

    Article  PubMed  Google Scholar 

  85. Smets EM, Garssen B, Bonke B, De Haes JC (1995) The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39(3): 315–325

    Article  PubMed  CAS  Google Scholar 

  86. Zimet GD, Powell SS, Farley GK, Werkman S, Berkoff KA (1990) Psychometric characteristics of the multidimensional scale of perceived social support. J Pers Assess 55(3–4):610–617

    PubMed  CAS  Google Scholar 

  87. Havekes B, van der Klaauw AA, Hoftijzer HC, Jansen JC, van der Mey AG, Vriends AH et al (2008) Reduced quality of life in patients with head-and-neck paragangliomas. Eur J Endocrinol 158(2):247–253

    Article  PubMed  CAS  Google Scholar 

  88. Chelune GJ, Heaton RK, Lehman RA (1986) Neuropsychological and personality correlates of patients’ complaints of disability. In: Gerald Goldstein RET (ed) Advances in clinical neuropsychology. Plenum Press, New York

    Google Scholar 

  89. Nyenhuis DL, Yamamoto C, Luchetta T, Terrien A, Parmentier A (1999) Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol 55(1):79–86

    Article  PubMed  CAS  Google Scholar 

  90. Trask PC, Paterson AG, Wang C, Hayasaka S, Milliron KJ, Blumberg LR et al (2001) Cancer-specific worry interference in women attending a breast and ovarian cancer risk evaluation program: impact on emotional distress and health functioning. Psychooncology 10(5):349–360

    Article  PubMed  CAS  Google Scholar 

  91. Andresen EM, Rothenberg BM, Kaplan RM (1998) Performance of a self-administered mailed version of the quality of well-being (QWB-SA) questionnaire among older adults. Med Care 36(9):1349–1360

    Article  PubMed  CAS  Google Scholar 

  92. Pyne JM, Sieber WJ, David K, Kaplan RM, Hyman Rapaport M, Keith Williams D (2003) Use of the quality of well-being self-administered version (QWB-SA) in assessing health-related quality of life in depressed patients. J Affect Disord 76(1–3):237–247

    Article  PubMed  Google Scholar 

  93. Vacek PM, Winstead-Fry P, Secker-Walker RH, Hooper GJ, Plante DA (2003) Factors influencing quality of life in breast cancer survivors. Qual Life Res 12(5):527–537

    Article  PubMed  Google Scholar 

  94. Agra Y, Badia X (1998) Spanish version of the Rotterdam symptom check list: cross-cultural adaptation and preliminary validity in a sample of terminal cancer patients. Psychooncology 7(3):229–239

    Article  PubMed  CAS  Google Scholar 

  95. Fortner BV, Houts AC, Schwartzberg LS (2006) A prospective investigation of chemotherapy-induced neutropenia and quality of life. J Support Oncol 4(9):472–478

    PubMed  CAS  Google Scholar 

  96. Bergner M, Bobbitt RA, Carter WB, Gilson BS (1981) The sickness impact profile: development and final revision of a health status measure. Med Care 19(8):787–805

    Article  PubMed  CAS  Google Scholar 

  97. Goedendorp MM, Gielissen MF, Verhagen CA, Peters ME, Bleijenberg G (2008) Severe fatigue and related factors in cancer patients before the initiation of treatment. Br J Cancer 99(9):1408–1414

    Article  PubMed  CAS  Google Scholar 

  98. Spielberger CD, Gorsuch RL, Lushene PR, Vagg PR, Jacobs AG (1983) Manual for the state-trait anxiety inventory (Form Y). Consulting Psychologists Press, Inc., Palo Alto, CA

    Google Scholar 

  99. Sukegawa A, Miyagi E, Asai-Sato M, Saji H, Sugiura K, Matsumura T et al (2008) Anxiety and prevalence of psychiatric disorders among patients awaiting surgery for suspected ovarian cancer. J Obstet Gynaecol Res 34(4):543–551

    Article  PubMed  Google Scholar 

  100. Den Oudsten BL, Van Heck GL, Van der Steeg AF, Roukema JA, De Vries J (2009) The WHOQOL-100 has good psychometric properties in breast cancer patients. J Clin Epidemiol 62(2):195–205

    Article  Google Scholar 

  101. The WHOQOL Group (1998) The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 46(12): 1569–1585

    Article  Google Scholar 

  102. Schag CA, Ganz PA, Heinrich RL (1991) Cancer rehabilitation evaluation system-short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument. Cancer 68(6): 1406–1413

    Article  PubMed  CAS  Google Scholar 

  103. Ringdal K, Ringdal GI, Kaasa S, Bjordal K, Wisloff F, Sundstrom S et al (1999) Assessing the consistency of psychometric properties of the HRQoL scales within the EORTC QLQ-C30 across populations by means of the Mokken scaling model. Qual Life Res 8(1–2):25–43

    Article  PubMed  CAS  Google Scholar 

  104. Ferrans CE, Powers MJ (1985) Quality of life index: development and psychometric properties. ANS Adv Nurs Sci 8(1):15–24

    PubMed  CAS  Google Scholar 

  105. Ferrans CE, Powers MJ (1992) Psychometric assessment of the quality of life index. Res Nurs Health 15(1):29–38

    Article  PubMed  CAS  Google Scholar 

  106. Gupta D, Grutsch JF, Lis CG (2008) Patient satisfaction with quality of life as a prognostic indicator in ovarian cancer patients treated in an integrative treatment setting. J Soc Integr Oncol 6(3):98–104

    PubMed  Google Scholar 

  107. Fox S (2004) Preliminary psychometric testing of the fox simple quality-of-life scale. J Neurosci Nurs 36(3):157–166

    Article  PubMed  Google Scholar 

  108. Kornblith AB, Thaler HT, Wong G, Vlamis V, Lepore JM, Loseth DB et al (1995) Quality of life of women with ovarian cancer. Gynecol Oncol 59(2):231–242

    Article  PubMed  CAS  Google Scholar 

  109. Lindley CM, Hirsch JD, O’Neill CV, Transau MC, Gilbert CS, Osterhaus JT (1992) Quality of life consequences of chemotherapy-induced emesis. Qual Life Res 1(5):331–340

    Article  PubMed  CAS  Google Scholar 

  110. Martin AR, Pearson JD, Cai B, Elmer M, Horgan K, Lindley C (2003) Assessing the impact of chemotherapy-induced nausea and vomiting on patients’ daily lives: a modified version of the functional living index-emesis (FLIE) with 5-day recall. Support Care Cancer 11(8): 522–527

    Article  PubMed  CAS  Google Scholar 

  111. Coates A, Glasziou P, McNeil D (1990) On the receiving end – III. Measurement of quality of life during cancer chemotherapy. Ann Oncol 1(3):213–217

    PubMed  CAS  Google Scholar 

  112. Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B (2008) Refinement and psychometric evaluation of the impact of cancer scale. J Natl Cancer Inst 100(21):1530–1541

    Article  PubMed  Google Scholar 

  113. Downs KM, Wagner MK (1991) The development of an individualized quality of life scale for cancer patients. Presented at the Annual Meeting of the Southeastern Psychological Association New orleans LA, April, 1991

    Google Scholar 

  114. Downs KM, Wagner MK (1992) The individualized quality of life scale (IQOLS): psychometric properties and comparative population norms. Paper presented at the Annual Meeting of the Southeastern Psychological Association, knoxville, TN, march, 1992

    Google Scholar 

  115. Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M et al (2000) Assessing symptom distress in cancer patients: the M.D. Anderson symptom inventory. Cancer 89(7): 1634–1646

    Article  PubMed  CAS  Google Scholar 

  116. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E et al (1994) The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A(9):1326–1336

    Article  PubMed  CAS  Google Scholar 

  117. Northouse LFOR (1981) Questionnaire – patient version [cited June 17, 2009]. http://www.nursing.umich.edu/faculty/northouse/fearpt.pdf, http://www.nursing.umich.edu/faculty/northouse/fearscore.pdf

  118. Mark TL, Fortner B, Johnson G (2008) Evaluation of a tablet PC technology to screen and educate oncology patients. Support Care Cancer 16(4):371–378

    Article  PubMed  Google Scholar 

  119. Padilla GV, Presant C, Grant MM, Metter G, Lipsett J, Heide F (1983) Quality of life index for patients with cancer. Res Nurs Health 6(3):117–126

    Article  PubMed  CAS  Google Scholar 

  120. Ferrell BR, Wisdom C, Wenzl C (1989) Quality of life as an outcome variable in the management of cancer pain. Cancer 63(11 suppl):2321–2327

    Article  PubMed  CAS  Google Scholar 

  121. Smith AB, Wright P, Selby P, Velikova G (2007) Measuring social difficulties in routine patient-centred assessment: a Rasch analysis of the social difficulties inventory. Qual Life Res 16(5):823–831

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Indiana University School of Medicine, 714 N Senate Ave., Indianapolis, IN, 46202, USA

    Lisa M. Hess

Authors
  1. Lisa M. Hess
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa M. Hess .

Editor information

Editors and Affiliations

  1. College of Medicine, Arizona Cancer Center, University of Arizona, Tucson, Arizona, USA

    David S. Alberts

  2. Arizona Cancer Center, University of Arizona, N. Campbell Ave. 1515, Tucson, 85724-5024, Arizona, USA

    Mary C. Clouser

  3. School of Medicine, Deps of Pub. Health and Obstetrics and G, Indiana University, N. Senate Ave. EF250 714, Indianapolis, IN, 46202, Arizona, USA

    Lisa M. Hess

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Hess, L.M. (2010). Health-Related Quality of Life and Patient-Reported Outcomes. In: Alberts, D., Clouser, M., Hess, L. (eds) Intraperitoneal Therapy for Ovarian Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12130-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-12130-2_11

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-12129-6

  • Online ISBN: 978-3-642-12130-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation